USD 0.81
(-5.81%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | -16.39 Thousand | -15.51 Thousand | -14.33 Thousand | -40.89 Thousand | - | -1236.00 |
Net Income | -1.61 Million | -1.61 Million | -1.61 Million | -5.61 Million | 49.8 Million | -28.8 Thousand |
Depreciation & Amortization | 1.6 Million | 1.6 Million | 1.6 Million | 5.6 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -22.96 Thousand | 21.75 Thousand | -7715.00 |
Other non-cash items | - | - | - | 11.2 Million | -49.82 Million | 35.28 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 16.39 Thousand | 15.51 Thousand | 14.33 Thousand | 40.87 Thousand | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 16.39 Thousand | 15.51 Thousand | 14.33 Thousand | 40.87 Thousand | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | -22.96 Thousand | 21.75 Thousand | -7715.00 |
Cash at beginning of period | - | - | - | 21.00 | - | 1257.00 |
Cash at end of period | - | - | - | -21.00 | - | 21.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | -42.00 | - | -1236.00 |
Free Cash Flow | -16.39 Thousand | -15.51 Thousand | -14.33 Thousand | -40.89 Thousand | - | -1236.00 |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -405.71 Thousand | -402.41 Thousand | -404.87 Thousand | -401.71 Thousand | -1.61 Million | -406.06 Thousand |
Depreciation & Amortization | 400 Thousand | 400 Thousand | 400 Thousand | 400 Thousand | 1.6 Million | 400 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 5719.00 | 2412.00 | 4873.00 | 1712.00 | 16.39 Thousand | 6062.00 |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 5719.00 | 2412.00 | 4873.00 | 1712.00 | 16.39 Thousand | 6062.00 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | -5719.00 | -2412.00 | -4873.00 | -1712.00 | -16.39 Thousand | -6062.00 |
PEB-PG
ABLV
FNINF
7TEC
BVNNF
ARTEMISMED